Journal Home > Volume 4 , Issue 12

Ultrasmall FeCo–graphitic carbon shell nanocrystals (FeCo/GC) are promising multifunctional materials capable of highly efficient drug delivery in vitro and magnetic resonance imaging in vivo. In this work, we demonstrate the use of FeCo/GC for highly effective cancer therapy through combined drug delivery, tumor-selective near-infrared photothermal therapy, and cancer imaging of a 4T1 syngeneic breast cancer model. The graphitic carbon shell of the ~4 nm FeCo/GC readily loads doxorubicin (DOX) via π–π stacking and absorbs near-infrared light giving photothermal heating. When used for cancer treatment, intravenously administrated FeCo/GC–DOX led to complete tumor regression in 45% of mice when combined with 20 min of near-infrared laser irradiation selectively heating the tumor to 43–45 ℃. In addition, the use of FeCo/GC–DOX results in reduced systemic toxicity compared with free DOX and appears to be safe in mice monitored for over 1 yr. FeCo/GC–DOX is shown to be a highly integrated nanoparticle system for synergistic cancer therapy leading to tumor regression of a highly aggressive tumor model.

File
12274_2011_176_MOESM1_ESM.pdf (370.4 KB)
Publication history
Copyright
Acknowledgements

Publication history

Received: 25 July 2011
Revised: 22 September 2011
Accepted: 27 September 2011
Published: 04 November 2011
Issue date: December 2011

Copyright

© Tsinghua University Press and Springer-Verlag Berlin Heidelberg 2011

Acknowledgements

Acknowledgements

The authors acknowledge the Stanford Center for Innovation in In Vivo Imaging (SCI3) for small animal imaging equipment. The authors acknowledge Guangchao Li at Stanford Environmental Measurement 1 for assistance with ICP–MS, Liming Xie for TEM, and Scott Tabakman, Kevin Welsher and Joshua Robinson for helpful discussions. This work was supported by the National Institute of Health (No. NIH-NCI 5R01CA135109-02).

Return